Marcaine
NDC Package 0409-7510-25

11-digit billing NDC: 00409751025

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Marcaine is / MARCAINE WITH EPINEPHRINE is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Marketed by Hospira, Inc., this product is identified by NDC 0409-7510 and is authorized under FDA application NDA016964.

Identification & Billing

NDC Package Code
0409-7510-25
Package Description
25 VIAL, SINGLE-DOSE in 1 TRAY / 10 mL in 1 VIAL, SINGLE-DOSE (0409-7510-01)
Product Code
11-Digit Billing Format
00409751025
RxNorm Crosswalk
  • RxCUI: 1012377 - BUPivacaine HCl 0.25 % / EPINEPHrine 1:200,000 Injectable Solution
  • RxCUI: 1012377 - bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution
  • RxCUI: 1012377 - bupivacaine hydrochloride 0.25 % / epinephrine (as epinephrine bitartrate) 1:200,000 Injectable Solution
  • RxCUI: 1012381 - Marcaine 0.25 % / EPINEPHrine 1:200,000 Injectable Solution
  • RxCUI: 1012381 - bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution [Marcaine with Epinephrine]

Clinical Specifications

Proprietary Name
Marcaine
Dosage Form
-
Usage Information
MARCAINE / MARCAINE WITH EPINEPHRINE is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of MARCAINE / MARCAINE WITH EPINEPHRINE are recommended for each type of block indicated to produce local or regional anesthesia or analgesia [see Dosage and Administration (2.2)].

Regulatory & Marketing

Labeler Name
Hospira, Inc.
FDA Application #
NDA016964
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-09-2024
End Marketing Date
12-09-2024
Listing Expiration
12-09-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0409-7510-25 identifies a specific commercial package of 25 vial, single-dose in 1 tray / 10 ml in 1 vial, single-dose (0409-7510-01) of Marcaine, labeled by Hospira, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hospira, Inc. on December 09, 2024. The current certification is valid through December 09, 2024.

How is this Hospira, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00409751025. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0409-7510-25
11-Digit CMS (5-4-2)
00409-7510-25

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.